General Information
Version
3
Revision date
2017-05-02
Product name
Thinner No.9
1.2.1 Relevant identified uses
Consumer application of coatings Professional application of coatings and inks
1.2.2. Uses advised against
Reason
Emergency telephone
+44 (0)191 469 6111, +44 (0)191 438 3711, +44 (0)844 892 0111
Icons in SDS
Company Information
company name
International Paint Ltd
e-mail address of the competent person responsible for the Safety Data Sheet
sdsfellinguk@akzonobel.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H226, H319
Hazard statements
Code
Statements
H226
Flammable liquid and vapour
Section 2
SECTION 2: Hazards identification
1272/2008] Classification of the substance or mixture
Product definition
Mixture
Signal word
Warning
Hazard statements
Flammable liquid and vapour. Causes serious eye irritation.
Precautionary statements
General Read label before use. Keep out of reach of children. If medical advice is needed, have product container or label at hand.
Prevention
Wear protective gloves. Wear eye or face protection. Keep away from heat, hot surfaces, sparks, open flames and other ignition sources. No smoking.
Response
IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water or shower. IF IN EYES: Rinse cautiously with water for several minutes.
Storage
Keep cool.
Disposal
Dispose of contents and container in accordance with all local, regional, national and international regulations.
Supplemental label elements
elements Wear appropriate respirator when ventilation is inadequate.
Annex XVII - Restrictions on the manufacture, placing on the market and use of certain dangerous substances, mixtures and articles
Not applicable.
Other hazards which do not result in classification
None known.
2.1 Classification of the substance or mixture
Product definition : Mixture Classification according to Regulation (EC) No. 1272/2008 [CLP/GHS] Flam. Liq. 3, H226 Eye Irrit. 2, H319 The product is classified as hazardous according to Regulation (EC) 1272/2008 as amended. See Section 16 for the full text of the H statements declared above. See Section 11 for more detailed information on health effects and symptoms.
